The Lynx Group

Benjamin Kim, MD, MPhil


Assistant Professor of Clinical Medicine at the University of California San Francisco School of Medicine.

Authored Items

Physician-Reported Clinical Utility of the 92-Gene Molecular Classifier in Tumors With Uncertain Diagnosis Following Standard Clinicopathologic Evaluation

April 2013, Vol 2, No 2 - Uncategorized

Advances in understanding the genetic basis of many cancers and the development of molecularly targeted therapies are increasing the need for diagnostic resolution. Patient outcomes have improved with the use of predictive biomarker testing, targeted therapies, and site-specific chemotherapy regimens.1,2 However, tumor classification remains unknown or uncertain in a quarter [ Read More ]

Sign me up!